Page last updated: 2024-08-23

tetradecanoylphorbol acetate and sr 11302

tetradecanoylphorbol acetate has been researched along with sr 11302 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dawson, MI; Dong, Z; Flavell, RA; Huang, C; Ma, WY; Rincon, M1
Colburn, NH; Ghosh, P; Li, JJ; Westergaard, C1

Other Studies

2 other study(ies) available for tetradecanoylphorbol acetate and sr 11302

ArticleYear
Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid.
    Proceedings of the National Academy of Sciences of the United States of America, 1997, May-27, Volume: 94, Issue:11

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Female; Fluocinolone Acetonide; Luciferases; Male; Mice; Mice, Transgenic; Papilloma; Recombinant Fusion Proteins; Regulatory Sequences, Nucleic Acid; Retinoids; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcriptional Activation; Tretinoin

1997
Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
    Cancer research, 1997, Aug-15, Volume: 57, Issue:16

    Topics: Animals; Anticarcinogenic Agents; Carcinogens; Cell Transformation, Neoplastic; Cells, Cultured; DNA; Genes, Reporter; Mice; NF-kappa B; Pyrrolidines; Retinoids; Tetradecanoylphorbol Acetate; Thiocarbamates; Time Factors; Transcription Factor AP-1; Transcriptional Activation; Transfection; Tumor Necrosis Factor-alpha

1997